News

Nipah virus: The deadly illness without a vaccine

Causing rapidly progressive illness, including inflammation of the brain, Nipah virus is one of the deadliest pathogens known to infect humans. We must advance research and develop tools to protect against this disease.

05 Nov 2021

CEPI announces funding for 'variant-proof' COVID-19 vaccines

Partnerships with MigVax Ltd and University of Saskatchewan's Vaccine & Infectious Disease Organization kick off programme to develop broadly protective vaccines against COVID-19 variants and other coronaviruses.

04 Nov 2021

Could chicken eggs help end the COVID-19 pandemic?

CEPI is supporting PATH's work as part of an international consortium developing a new egg-based vaccine to tackle COVID-19, inspired by influenza vaccines in longtime use.

11 Oct 2021

CEPI enters into funding agreement with Gritstone bio to develop COVID-19 variant vaccine

Programme forms part of CEPI’s efforts to develop “next-generation” COVID-19 vaccines

17 Aug 2021

Largest ever Lassa fever study expands to more countries in West Africa

Up to 23,000 participants will be enrolled into the research programme in Benin, Guinea, Liberia, and Sierra Leone, as well as Nigeria, which began collecting data in December 2020.

28 Jul 2021

From lab to potential jab: Clover’s COVID-19 vaccine story

CEPI’s early investment in Clover has been key to accelerating development and equitable access to this promising vaccine.

01 Jul 2021

UK to host global vaccine development summit with CEPI

The UK will host a summit with the Coalition for Epidemic Preparedness Innovations (CEPI) – a leading scientific coalition – to raise funds for vaccine research and development. The 2022 summit will support the UK and CEPI’s goal of cutting vaccine development time by two-thirds, to 100 days, which could avert future pandemics and save...

30 Apr 2021

1 2 3 4 5 6